Evaluating cardiovascular pathophysiology and anatomy in atherosclerosis

Peter H Stone1

  • 1Clinical Trials Center, Samuel A. Levine Cardiac Unit, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. pstone@partners.org

Insights

Atherosclerosis involves endothelial dysfunction and plaque buildup, increasing cardiovascular risk. Early detection via flow-mediated dilation and intravascular ultrasound aids in preventing adverse events with lipid-lowering therapy.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Diagnostic Imaging

Background:

  • Atherosclerosis initiates with endothelial dysfunction, characterized by reduced nitric oxide (NO) bioavailability.
  • This dysfunction promotes the accumulation of oxidized low-density lipoprotein cholesterol, leading to arterial plaque formation.
  • Plaque rupture can cause acute coronary events through thrombus formation and vessel occlusion.

Purpose of the Study:

  • To outline the stages of atherosclerosis, from endothelial dysfunction to plaque rupture.
  • To highlight emerging diagnostic techniques for early detection of endothelial dysfunction and plaque formation.
  • To emphasize the potential of early diagnosis for risk stratification and preventative interventions.

Main Methods:

  • Review of the pathophysiological process of atherosclerosis.
  • Description of diagnostic modalities including flow-mediated dilation (FMD) of the brachial artery.
  • Explanation of intravascular ultrasound (IVUS) for detecting early arterial plaque.

Main Results:

  • Endothelial dysfunction is a key early step, decreasing NO and increasing oxidized LDL.
  • Oxidized LDL accumulation in the subendothelial space forms atherosclerotic plaques.
  • Advanced imaging can identify endothelial dysfunction and early plaque, enabling risk assessment.

Conclusions:

  • Early identification of endothelial dysfunction and plaque formation is crucial for cardiovascular risk management.
  • Diagnostic tools like FMD and IVUS offer promise in identifying at-risk patients.
  • Timely initiation of therapies, such as lipid-lowering treatment, can potentially prevent adverse cardiovascular outcomes.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...